Skip to main content
SpringerLink
Log in

Growth hormone beneficial in osteoporosis, no effects on QOL

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Krantz E, et al. Effect of Growth Hormone Treatment on Fractures and Quality of Life in Postmenopausal Osteoporosis: A 10-Year Follow-Up Study. Journal of Clinical Endocrinology and Metabolism : jc20151757, 27 Aug 2015. Available from: URL: http://doi.org/10.1210/jc.2015-1757

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Growth hormone beneficial in osteoporosis, no effects on QOL. PharmacoEcon Outcomes News 737, 29 (2015). https://doi.org/10.1007/s40274-015-2475-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2475-1

Search

Navigation